Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and Evolution

Area of Science:

• Cardiovascular Medicine
• Biomaterials Science
• Interventional Cardiology

Background:

• Bioresorbable scaffolds (BRS) are a new approach in interventional cardiology, aiming to overcome limitations of metallic drug-eluting stents.
• Potential benefits include restoring vascular function, promoting remodeling, and reducing long-term adverse events.
• First-generation BRS have manufacturing issues and require precise implantation to ensure clinical success.

Purpose of the Study:

• To review the clinical outcomes of available and emerging bioresorbable scaffolds.
• To focus on recent clinical trial data and future directions for various BRS technologies.
• To compare the advancements in BRS, particularly thinner strut designs.

Main Methods:

• Review of clinical trial data for commercially available and investigational BRS.
• Analysis of device iterations, including those with thinner struts (<150 μm).
• Focus on recent clinical development stages and future prospects.

Main Results:

• First-generation BRS show promise but have manufacturing limitations and implantation technique dependencies.
• Numerous BRS devices are in development, with a trend towards thinner struts.
• Ongoing trials are evaluating the efficacy and safety of next-generation BRS.

Conclusions:

• Bioresorbable scaffolds represent a significant evolution in cardiovascular interventions.
• Continued innovation is addressing the limitations of early BRS, with thinner struts being a key development.
• Future research will determine the long-term clinical impact and optimal use of advanced BRS.